Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury. [electronic resource]
Producer: 20110831Description: 1330-40 p. digitalISSN:- 1743-6109
- Animals
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Erectile Dysfunction -- drug therapy
- Hedgehog Proteins -- analysis
- Hypoxia-Inducible Factor 1, alpha Subunit -- analysis
- Male
- Nerve Growth Factor -- analysis
- Nitric Oxide Synthase Type I -- analysis
- Nitric Oxide Synthase Type III -- analysis
- Penile Erection -- drug effects
- Penis -- chemistry
- Phosphodiesterase 5 Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Receptor, Endothelin B -- analysis
- Sulfonamides -- administration & dosage
- Transforming Growth Factor beta1 -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.